Delivery Order SPE2DB20D2014-SPE2DB25FC94R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,262.89 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,819.74 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 20 mg, a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $3,558.49 under a firm fixed-price contract. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical product is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Escitalopram 20 mg tablets in a quantity of 1,000 units, with a firm fixed price ceiling value of $4,295.66. The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) valued at $2,912.46. This non-competitive, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly used to treat depression and...
- The Defense Logistics Agency awarded a delivery order valued at $1,507.57 to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly prescribed for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,930.56 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Escitalopram 10 mg, a generic selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- The U.S. Department of Defense, through its Medical Supply Chain organization, awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Escitalopram 10mg tablets in a quantity of 1,000 units. This firm fixed-price delivery order, valued at $3,103.26, represents a non-competitive set-aside award and is scheduled for completion by October 1, 2025. The performance location is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- The Defense Logistics Agency awarded a $1,627.52 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with performance scheduled for completion by September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. This award...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC94RDelivery Order
The Defense Logistics Agency awarded a $4,884.40 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with completion required by September 9, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of generic and brand-name medications to support military and veteran healthcare systems. This delivery order for Escitalopram, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders, exemplifies the company's role in fulfilling ongoing pharmaceutical needs across the Department of Defense healthcare enterprise. The prime IDC vehicle enables AmerisourceBergen to efficiently deliver diverse medical commodities across multiple therapeutic domains to support global military healthcare programs and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/8/25 |